China Universal Asset Management Company’s Charles River Laboratories CRL Stock Holding History

China Universal Asset Management Company’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+1,000	New	+$178K	0.01%	343
2025 Q3	–	Sell	-89	Closed	-$13.5K	–	486
2025 Q2	$13.5K	Hold	89	–	–	﹤0.01%	461
2025 Q1	$13.4K	Hold	89	–	–	﹤0.01%	468
2024 Q4	$16.4K	Hold	89	–	–	﹤0.01%	488
2024 Q3	$17.5K	Hold	89	–	–	﹤0.01%	408
2024 Q2	$18.4K	Hold	89	–	–	﹤0.01%	393
2024 Q1	$24.1K	Hold	89	–	–	﹤0.01%	424
2023 Q4	$21K	Hold	89	–	–	﹤0.01%	408
2023 Q3	$17.4K	Hold	89	–	–	0.01%	307
2023 Q2	$18.7K	Hold	89	–	–	0.01%	275
2023 Q1	$18K	Hold	89	–	–	0.01%	231
2022 Q4	$19.4K	Sell	89 -11,677	-99%	-$2.55M	0.01%	174
2022 Q3	$2.32M	Buy	11,766 +11,677	+13,120%	+$2.52M	0.97%	39
2022 Q2	$19K	Sell	89 -3,125	-97%	-$764K	0.01%	83
2022 Q1	$913K	Sell	3,214 -5,297	-62%	-$1.63M	0.32%	58
2021 Q4	$3.21M	Buy	+8,511	New	+$3.31M	0.76%	40

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

China Universal Asset Management Company's CRL Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Charles River Laboratories (CRL) in Q2 2026: 1,000 shares worth $227K. The stake represents 0.01% of the portfolio and ranks #343 among its holdings. This is a return to the name: China Universal Asset Management Company previously reported a position in CRL as recently as Q2 2025.

China Universal Asset Management Company first reported a position in CRL in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.21M in Q4 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

China Universal Asset Management Company held 1,000 shares of Charles River Laboratories worth $227K as of Q2 2026.
Charles River Laboratories was a new China Universal Asset Management Company position in Q2 2026.
Charles River Laboratories made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #343 holding.
China Universal Asset Management Company first reported a position in Charles River Laboratories in Q4 2021 and has held it in 16 quarters since.
China Universal Asset Management Company's Charles River Laboratories position peaked at $3.21M in Q4 2021.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.